BATS BZX Real-Time Price
As of 11:21am ET
| +0.49 / +18.08%|
The 4 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 2.25, with a high estimate of 6.00 and a low estimate of 2.00. The median estimate represents a -29.69% decrease from the last price of 3.20.
The current consensus among 5 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since February, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.